Welcome to Medications.com

Kadian News

Campbell cool with Tivoli win - Jamaica Gleaner

Arnett's Kadian Mendez scored 32 goals from 48 attempts to lead her team. Defending champions Jamalco were not in action on the opening day.

Posted: Mon Mar 10 00:11:32 -0400 2008

Alpharma Inc. Q4 2007 Earnings Call Transcript - Seeking Alpha

Our Pharmaceuticals business had record revenues with impressive growth of 40% in the quarter reflecting increased KADIAN volumes and price. ...

http://seekingalpha.com/article/6... | Posted: Mon Mar 10 13:04:24 -0400 2008

Disqualification case against Bhajan Lal deferred to March 24 - Times of India

... but with regards to two other MLAs the case has been adjourned to March 11," State Assembly Speaker, Raghubir Singh Kadian told in the state capital. ...

http://timesofindia.indiatimes.co... | Posted: Sat Mar 08 09:40:43 -0500 2008

Alpharma Submits New Drug Application for EMBEDATM - PR-USA.net (press release)

Alpharma has a growing branded pharmaceutical franchise in the US pain market with its KADIAN® (morphine sulfate extended-release) Capsules, ...

http://www.pr-usa.net/index.php?o... | Posted: Mon Mar 03 17:17:48 -0500 2008

Alpharma Reports Double-Digit Full Year and Fourth Quarter 2007 ... - CNNMoney.com

Pharmaceuticals: Revenues of the Company's branded product, KADIAN®, increased 40% to a record $48.2 million in the fourth quarter of 2007, ...

http://money.cnn.com/news/newsfee... | Posted: Tue Feb 26 07:06:35 -0500 2008

Bhajan counsels fight plea disposal - Times of India

Meanwhile, Vidhan Sabha speaker Raghbhir Singh Kadian adjourned hearing in the case to Monday for recording evidence of two other petitioner MLAs and their ...

http://timesofindia.indiatimes.co... | Posted: Fri Feb 29 20:03:01 -0500 2008

Alpharma Reports Double-Digit Full Year and Fourth Quarter 2007 ... - Market Wire (press release)

Pharmaceuticals: Revenues of the Company's branded product, KADIAN®, increased 40% to a record $48.2 million in the fourth quarter of 2007, ...

http://www.marketwire.com/mw/rele... | Posted: Tue Feb 26 07:05:12 -0500 2008

UPDATE 1-Alpharma posts Q4 results above market estimates - Reuters

N: Quote, Profile, Research) posted fourth-quarter results above market estimates driven by a 40 percent jump in revenue from its pain reliever Kadian. ...

http://www.reuters.com/article/ma... | Posted: Tue Feb 26 10:09:39 -0500 2008

Alpharma Submits New Drug Application for EMBEDA(TM) - CNNMoney.com

all 9 news articles

Posted: Thu Feb 28 16:48:06 -0500 2008

S&P Equity Research Upgrades Alpharma (ALO) to Buy - StreetInsider.com (subscription)

We attribute robust Q4 to strength in Kadian pain drug, with 40% higher sales, and well-controlled SG&A costs. ALO will update '08 guidance after sale of ...

http://www.streetinsider.com/Upgr... | Posted: Tue Feb 26 15:54:54 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea